Robert Popescu, CEO of A&D Pharma, the biggest domestic pharmaceutical group, with turnover worth around half a billion euros, believes the rebound of West European economies will trigger a rebound of the Romanian economy, and the first field where this will become visible is the automotive one. "I have no reasons to believe the first half of the year will look better. The big hope is for the second half and it is based on external factors. In the extent to which Western Europe starts registering economic growth, this will have, with a certain delay, for sure, a 'tractor' effect for us, too. This is because we have a lot of plants producing for export purposes. If things start to move in the automotive industry (of the West i.e.), they will begin to move here, too, because the market is vertically integrated," Popescu told ZF in an interview. Popescu, who came at the helm of A&D in the summer of 2008, believes economic rebound will not bring the same "exuberance" characteristic of the years before the crisis, because managers have seen increases and profits can be generated even during a crisis period.
Robert Popescu, CEO of A&D Pharma, the biggest domestic pharmaceutical group, with turnover worth around half a billion euros, believes the rebound of West European economies will trigger a rebound of the Romanian economy, and the first field where this will become visible is the automotive one. "I have no reasons to believe the first half of the year will look better. The big hope is for the second half and it is based on external factors. In the extent to which Western Europe starts registering economic growth, this will have, with a certain delay, for sure, a 'tractor' effect for us, too. This is because we have a lot of plants producing for export purposes. If things start to move in the automotive industry (of the West i.e.), they will begin to move here
